Main objective: Preclinical confirmation of systems biology findings
Griet Glorieux
MC Member, WG3 Leader
MC Member, WG3 Leader
Griet Glorieux is professor at Ghent University Hospital since 2012. Her research topics focuses on chronic kidney disease (CKD) and uraemic toxicity to develop therapeutic measures/therapeutic strategies to alter the intestinal generation of uraemic toxins, resulting in lowering their circulating levels, aiming at decreasing inflammation and cardiovascular morbidity and mortality in CKD patients.
Ghent University/ Ghent University Hospital
Belgium
Tasks
- 1. Define the demands for suitable preclinical models with translational predictive value.
- 2. Confirm the disease models on molecular pathophysiology generated in WG2 in data from human specimens (tissue and body fluids), primary cells, cell lines, advanced in vitro models.
- 3. And animal models of CKD
- 4. Define cross-species molecular similarity, based on affected pathways.
Meet the others Working Groups
Working Group 2
Main objective: Bioinformatics CKD modelling. WG 2 Leader: Prof. Riste Stojanov
Working Group 5
Main objective: Management and Development of guidelines for implementation. WG 5 Leader: Prof Julija VOICEHOVSKA.
